Persistent GnRH receptor activation in pituitary αT3-1 cells analyzed with a label-free technology

Biosensors & Bioelectronics
I NederpeltLaura H Heitman

Abstract

The gonadotropin-releasing hormone (GnRH) receptor is a drug target for certain hormone-dependent diseases such as prostate cancer. In this study, we examined the activation profiles of the endogenous ligand, GnRH and a well-known marketed analog, buserelin using a label-free assay in pituitary αT3-1 cells with endogenous GnRH receptor expression. This whole cell impedance-based technology allows for the real-time measurement of morphological cellular changes. Both agonists dose-dependently decreased the impedance as a result of GnRH receptor activation with potencies of 9.3 ± 0.1 (pEC50 value, buserelin) and 7.8 ± 0.06 (pEC50 value, GnRH). Subsequently, GnRH receptor activation was completely abolished with a selective Gαq inhibitor, thereby confirming the Gαq-coupling of the GnRH receptor in pituitary αT3-1 cells. Additionally, we observed continued responses after agonist stimulation of αT3-1 cells indicating long-lasting cellular effects. Wash-out experiments demonstrated that the long-lasting effects induced by GnRH were most likely caused by rebinding since over 70% of the original response was abolished after wash-out. In contrast, a long receptor residence time was responsible for the prolonged effects caused by buserel...Continue Reading

References

Oct 10, 2001·Human Fertility : Journal of the British Fertility Society·S F Marcus, W L Ledger
Nov 23, 2006·Assay and Drug Development Technologies·Josephine M AtienzaYama A Abassi
Apr 25, 2007·The Journal of Biological Chemistry·Zhi-Liang LuRobert P Millar
Jun 19, 2007·The Journal of Pharmacology and Experimental Therapeutics·Erik LindströmGeorges Vauquelin
Apr 17, 2008·Biotechnology Journal·Biao XiYama A Abassi
Aug 19, 2008·Frontiers in Neuroendocrinology·Zvi Naor
Jul 6, 2010·Drug Discovery Today·Clay W Scott, Matthew F Peters
Oct 1, 2010·British Journal of Pharmacology·Georges Vauquelin, Steven J Charlton
Mar 2, 2011·The Journal of Pharmacology and Experimental Therapeutics·Paola CasarosaFlorian Gantner
Aug 11, 2011·Biochemical and Biophysical Research Communications·M KammermannC Hertel
Jan 24, 2012·Acta Pharmacologica Sinica·Ru Zhang, Xin Xie
Apr 7, 2012·European Journal of Medicinal Chemistry·Ulrike LeursMarilena Manea
Jun 1, 2012·Expert Opinion on Drug Discovery·Ye Fang
Jun 12, 2012·Mini Reviews in Medicinal Chemistry·C A McArdle
Jul 24, 2013·Molecular Pharmacology·Annelien J M ZweemerLaura H Heitman
Aug 13, 2013·Journal of Pharmacological and Toxicological Methods·Huayun DengYe Fang
Jul 6, 2015·Biosensors & Bioelectronics·Julia M HillgerLaura H Heitman

❮ Previous
Next ❯

Citations

Apr 17, 2017·Drug Discovery Today·Doris A SchuetzGerhard F Ecker
Nov 12, 2019·British Journal of Pharmacology·Stephen P H AlexanderUNKNOWN CGTP Collaborators

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.